The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 43 | — | 20.1x | Near average | |
Growth | 69 | — | 5.6% | Above average | |
Quality | 2 | -895.2% | 7.6% | Below average | |
Safety | 33 | 0.4x | 0.4x | Below average | |
Capital Return | 41 | — | 2.19% | Near average | |
Momentum | — | — | — | No data | |
Sentiment | — | — | — | No data |
Biohaven Ltd. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy Biohaven Ltd. shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
Biohaven stock has seen a significant improvement in analyst optimism over the past 30 days, with the average price target rising by 6.67% to reach $17.6. This increase is driven by 3 new analysts initiating coverage on the stock, bringing the total number of analysts to 15, while forecasts remained stable in the last week. This momentum reflects growing confidence in the stock's intrinsic value compared to its current price of $10.81.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.